Upon completing Module 1, students will be able to:

• Describe the natural history and epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD).
• Stratify MASLD severity using validated non-invasive tests.
• Apply recommended screening pathways to identify and assess at-risk patients.
• Non-invasively monitor MASLD progression.